Related Experiment Video
Updated: Jul 19, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
Imatinib mesylate-induced acute hepatitis with autoimmune features
Valérie Dhalluin-Venier1, Caroline Besson, Stéphanie Dimet
1Hepatogastroenterology, Bicêtre Hospital, LeKremlin Bicêtre, France. Valerie.dhalluin@bct.ap-hop-paris.fr
Imatinib mesylate, an anticancer drug, can cause autoimmune hepatitis. This is the first reported case of drug-induced hepatitis with autoimmune features linked to imatinib.
Area of Science:
- Hepatology
- Oncology
- Immunology
Background:
- Autoimmune hepatitis (AIH) is an idiopathic liver disease.
- Imatinib is a targeted anticancer agent for chronic myeloid leukemia and gastrointestinal tumors.
Observation:
- A patient developed hepatitis with autoimmune features.
Findings:
- The hepatitis was associated with imatinib mesylate treatment.
- This represents the first documented instance of imatinib mesylate-induced hepatitis exhibiting autoimmune characteristics.
Implications:
- This finding expands the known adverse effects of imatinib.
- Clinicians should consider imatinib as a potential cause of autoimmune-like hepatitis.
- Further research is needed to understand the mechanism of imatinib-induced autoimmune hepatitis.
Related Concept Videos
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Graves' Disease I: Introduction
Gastritis-I: Introduction and Types
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Type I Diabetes I: Introduction
Drug toxicity: Idiosyncratic Reactions
